476 related articles for article (PubMed ID: 24746743)
21. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
22. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
[TBL] [Abstract][Full Text] [Related]
23. A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders.
Vagios S; James KE; Sacha CR; Hsu JY; Dimitriadis I; Bormann CL; Souter I
Fertil Steril; 2021 Jan; 115(1):229-237. PubMed ID: 33077236
[TBL] [Abstract][Full Text] [Related]
24. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
Yue CY; Lu LK; Li M; Zhang QL; Ying CM
PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
[TBL] [Abstract][Full Text] [Related]
25. Advantages of Serum Anti-Müllerian Hormone as a Marker for Polycystic Ovarian Syndrome.
Shi X; Peng D; Liu Y; Miao X; Ye H; Zhang J
Lab Med; 2019 Jul; 50(3):236-242. PubMed ID: 30535164
[TBL] [Abstract][Full Text] [Related]
26. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome.
Woo HY; Kim KH; Rhee EJ; Park H; Lee MK
Endocr J; 2012; 59(9):781-90. PubMed ID: 22673409
[TBL] [Abstract][Full Text] [Related]
27. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
[TBL] [Abstract][Full Text] [Related]
28. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
29. Associations of different molecular forms of antimüllerian hormone and biomarkers of polycystic ovary syndrome and normal women.
Wissing ML; Mikkelsen AL; Kumar A; Kalra B; Pors SE; Flachs EM; Andersen CY
Fertil Steril; 2019 Jul; 112(1):149-155.e1. PubMed ID: 31056306
[TBL] [Abstract][Full Text] [Related]
30. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
[TBL] [Abstract][Full Text] [Related]
31. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
El-Mazny A; Abou-Salem N
Gynecol Endocrinol; 2013 Sep; 29(9):826-9. PubMed ID: 23855354
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
33. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
Wachs DS; Coffler MS; Malcom PJ; Chang RJ
J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
[TBL] [Abstract][Full Text] [Related]
34. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study.
Ahmad AK; Kao CN; Quinn M; Lenhart N; Rosen M; Cedars MI; Huddleston H
Fertil Steril; 2018 Mar; 109(3):526-531. PubMed ID: 29428308
[TBL] [Abstract][Full Text] [Related]
35. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T
Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296
[TBL] [Abstract][Full Text] [Related]
36. Anti-Müllerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.
Tian X; Ruan X; Mueck AO; Wang J; Liu S; Yin D; Lu Y; Wu H; Zhang Y
Gynecol Endocrinol; 2014 Feb; 30(2):126-9. PubMed ID: 24303884
[TBL] [Abstract][Full Text] [Related]
37. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
[TBL] [Abstract][Full Text] [Related]
38. Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome.
Fonseca HP; Brondi RS; Piovesan FX; Miklos TG; Aldrighi JM
Gynecol Endocrinol; 2014 Sep; 30(9):667-70. PubMed ID: 24898132
[TBL] [Abstract][Full Text] [Related]
39. Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
Acta Obstet Gynecol Scand; 2015 Mar; 94(3):279-87. PubMed ID: 25545309
[TBL] [Abstract][Full Text] [Related]
40. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women.
Pearce K; Gleeson K; Tremellen K
Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
